Unrealistic expectations and disclosure of incurability in patients with non-small cell lung cancer
- PMID: 38856947
- DOI: 10.1007/s00520-024-08630-z
Unrealistic expectations and disclosure of incurability in patients with non-small cell lung cancer
Abstract
Purpose: Determining whether patients' unrealistic expectations of chemotherapy as a cure were associated with their perception of the disclosure of incurability.
Methods: This prospective study included consecutive patients with pretreated non-small cell lung cancer from four study sites. Patients and their oncologists were asked whether they perceived the disclosure of cancer incurability. Patients were also asked if they thought that chemotherapy was curative. We followed up on whether the deceased patients received specialized palliative care 14 months after their last enrollment. Multiple regression analyses were conducted to examine the association between the expectation of chemotherapy as a cure and patient/oncologist-reported perceptions of the disclosure of incurability.
Results: We analyzed 200 patients, 77 (38.5%) of whom had unrealistic expectations of a cure. Based on patients' perceptions, incurability was disclosed to 138 (69.0%) patients, and based on their oncologists' perceptions, incurability was disclosed to 185 (92.5%) patients (patient/oncologist agreements, κ = 0.19). Patients without a perception of the oncologist's disclosure of incurability-regardless of their oncologist's perception-were more likely to have unrealistic expectations of a cure than patients for whom both patient and oncologist perceptions were present. Patients who had unrealistic expectations of chemotherapy as a cure were shown to be significantly less likely to have received specialized palliative care, after adjusting for covariates (adjusted OR, 0.45; 95% CI, 0.23-0.91; p = .027).
Conclusion: Oncologists' disclosure of incurability was not fully recognized by patients, and expectations of chemotherapy as a cure were associated with patients' perception of the disclosure of incurability.
Keywords: Advance care planning; Communication; End-of-life discussion; Lung cancer; Neoplasm; Palliative care.
© 2024. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Similar articles
-
Patient perceptions of curability and physician-reported disclosures of incurability in Japanese patients with unresectable/recurrent cancer: a cross-sectional survey.Jpn J Clin Oncol. 2018 Oct 1;48(10):913-919. doi: 10.1093/jjco/hyy112. Jpn J Clin Oncol. 2018. PMID: 30102399
-
Prognostic Awareness and Discussions of Incurability in Patients with Pretreated Non-Small Cell Lung Cancer and Caregivers: A Prospective Cohort Study.Oncologist. 2022 Nov 3;27(11):982-990. doi: 10.1093/oncolo/oyac178. Oncologist. 2022. PMID: 36067268 Free PMC article.
-
Outcomes of Prognostic Disclosure: Associations With Prognostic Understanding, Distress, and Relationship With Physician Among Patients With Advanced Cancer.J Clin Oncol. 2015 Nov 10;33(32):3809-16. doi: 10.1200/JCO.2015.61.9239. Epub 2015 Oct 5. J Clin Oncol. 2015. PMID: 26438121 Free PMC article.
-
Palliative care in cancer: managing patients' expectations.J Med Radiat Sci. 2016 Dec;63(4):242-257. doi: 10.1002/jmrs.188. Epub 2016 Aug 9. J Med Radiat Sci. 2016. PMID: 27741380 Free PMC article. Review.
-
Palliative chemotherapy for non-small cell lung cancer: a measured dose of reality.J Support Oncol. 2007 Jan;5(1):27-8. J Support Oncol. 2007. PMID: 17265783 Review. No abstract available.
Cited by
-
Expectations concerning cancer treatment: perspectives of medical oncologists and patients on advanced, unresectable lung carcinoma.Front Psychol. 2024 Oct 9;15:1392567. doi: 10.3389/fpsyg.2024.1392567. eCollection 2024. Front Psychol. 2024. PMID: 39444838 Free PMC article.
References
-
- Miller KD, Nogueira L, Devasia T et al (2022) Cancer treatment and survivorship statistics, 2022. CA Cancer J Clin 72:409–436. https://doi.org/10.3322/caac.21731 - DOI - PubMed
-
- Garon EB, Ciuleanu TE, Arrieta O et al (2014) Ramucirumab plus docetaxel versus placebo plus docetaxel for second-line treatment of stage IV non-small-cell lung cancer after disease progression on platinum-based therapy (REVEL): a multicentre, double-blind, randomised phase 3 trial. Lancet 384:665–673. https://doi.org/10.1016/S0140-6736(14)60845-X - DOI - PubMed
-
- Vlckova K, Tuckova A, Polakova K, Loucka M (2020) Factors associated with prognostic awareness in patients with cancer: a systematic review. Psycho-Oncology 29:990–1003. https://doi.org/10.1002/pon.5385 - DOI - PubMed
-
- Odejide OO, Cronin AM, Condron NB et al (2016) Barriers to quality end-of-life care for patients with blood cancers. J Clin Oncol 34:3126–3132. https://doi.org/10.1200/JCO.2016.67.8177 - DOI - PubMed
-
- Enzinger AC, Zhang B, Schrag D, Prigerson HG (2015) Outcomes of prognostic disclosure: associations with prognostic understanding, distress, and relationship with physician among patients with advanced cancer. J Clin Oncol 33:3809–3816. https://doi.org/10.1200/JCO.2015.61.9239 - DOI - PubMed - PMC
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical